Physician profile
Daniel J Calac
NPI 1730133372
$441.76
in general payments reported to CMS, 2019-2025
9 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.54 · 2021: $125 · 2022: $47.48 · 2023: $71.67 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $108.45 | 2021 | |
| Coopersurgical, INC. | $99.85 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $69.85 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Cranial Technologies, INC | $44.36 | 2019-2022 | |
| Solventum Corporation | $41.82 | 2025 | Snap, Activ.A.C. |
| Abbvie INC. | $23.23 | 2019 | |
| Indivior INC. | $19.18 | 2025 | Sublocade |
| Urgo Medical North America, LLC | $17.63 | 2025 | Urgoclean Ag |
| Merck Sharp & Dohme LLC | $17.39 | 2023 | Proquad, Vaxneuvance, Varivax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Calac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.